#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading

Posted on by Raj Gaurav Rai

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading

Please follow and like us:

Related Posts

The company signed a supplementary joint venture agreement with JV Partners of the National High Power Test Laboratory, i.e., NTPC, Powergrid, DVC, CPRI, and NHPTL, for the sale of a partial stake in NHPTL for a consideration of Rs 1.31 crore The company signed a supplementary joint venture agreement with JV Partners of the National High Power Test Laboratory, i.e., NTPC, Powergrid, DVC, CPRI, and NHPTL, for the sale of a partial stake in NHPTL for a consideration of Rs 1.31 crore

The company signed a supplementary joint venture agreement with JV Partners of the National High Power Test Laboratory, i.e., NTPC, Powergrid, DVC, CPRI, and NHPTL, […]